Table of Contents
ISRN Infectious Diseases
Volume 2013, Article ID 510840, 8 pages
http://dx.doi.org/10.5402/2013/510840
Research Article

Genital Infections of HIV-Infected Women Assisted by a Specialized Service

1Undergraduate Program, Botucatu School of Medicine (FMB), 18618970 Botucatu, SP, Brazil
2Nursing Department, FMB, 18618970 Botucatu, SP, Brazil
3Department of Tropical Diseases and Imaging Diagnosis, FMB, 18618970 Botucatu, SP, Brazil

Received 21 November 2012; Accepted 10 December 2012

Academic Editors: R. Bologna and D.-D. Ji

Copyright © 2013 Caroline Acquaro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Helfgott, N. Eriksen, C. M. Bundrick, R. Lorimor, and B. van Eckhout, “Vaginal infections in human immunodeficiency virus-infected women,” American Journal of Obstetrics and Gynecology, vol. 183, no. 2, pp. 347–355, 2000. View at Google Scholar · View at Scopus
  2. C. C. Wang, R. S. McClelland, M. Reilly et al., “The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1,” Journal of Infectious Diseases, vol. 183, no. 7, pp. 1017–1022, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. D. H. Watts, G. Springer, H. Minkoff et al., “The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study,” Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 2, pp. 161–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Atashili, C. Poole, P. M. Ndumbe, A. A. Adimora, and J. S. Smith, “Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies,” AIDS, vol. 22, no. 12, pp. 1493–1501, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. H. H. M. van De Wijgert, C. S. Morrison, P. G. A. Cornelisse et al., “Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women,” Journal of Acquired Immune Deficiency Syndromes, vol. 48, no. 2, pp. 203–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. B. van der Pol, C. Kwok, B. Pierre-Louis et al., “Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women,” Journal of Infectious Diseases, vol. 197, no. 4, pp. 548–554, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. B. E. Sha, M. R. Zariffard, Q. J. Wang et al., “Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis,” Journal of Infectious Diseases, vol. 191, no. 1, pp. 25–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Spinillo, F. Zara, B. Gardella, E. Preti, R. Mainini, and R. Maserati, “The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions,” American Journal of Obstetrics and Gynecology, vol. 192, no. 3, pp. 774–779, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Kissinger, A. Amedee, R. A. Clark et al., “Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding,” Sexually Transmitted Diseases, vol. 36, no. 1, pp. 11–16, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. J. Jamieson, A. Duerr, R. S. Klein et al., “Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study,” Obstetrics and Gynecology, vol. 98, no. 4, pp. 656–663, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Warren, R. S. Klein, J. Sobel et al., “A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection,” Infectious Diseases in Obstetrics and Gynecology, vol. 9, no. 3, pp. 133–141, 2001. View at Google Scholar · View at Scopus
  12. J. J. Schellenberg, C. M. Card, T. B. Ball et al., “Bacterial vaginosis, HIV serostatus and T cell subset distribution in a cohort of East African commercial sex workers: retrospective analysis,” AIDS, vol. 26, no. 3, pp. 387–393, 2011. View at Google Scholar
  13. M. Magnus, R. Clark, L. Myers, T. Farley, and P. J. Kissinger, “Trichomonas vaginalis among HIV Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity?” Sexually Transmitted Diseases, vol. 30, no. 11, pp. 839–843, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Kissinger, W. E. Secor, J. S. Leichliter et al., “Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women,” Clinical Infectious Diseases, vol. 46, no. 7, pp. 994–999, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Sobel, S. E. Ohmit, P. Schuman et al., “The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women,” Journal of Infectious Diseases, vol. 183, no. 2, pp. 286–293, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Duerr, C. M. Heilig, S. F. Meikle et al., “Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: risk factors and severity,” Obstetrics and Gynecology, vol. 101, no. 3, pp. 548–556, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ghosh, B. Dhawan, R. Chaudhry, M. Vajpayee, and V. Sreenivas, “Genital mycoplasma & Chlamydia trachomatis infections in the treatment of naïve HIV-1 infected adults,” Indian Journal of Medical Research, vol. 134, no. 6, pp. 960–966, 2011. View at Google Scholar
  18. A. Spinillo, G. Michelone, C. Cavanna, L. Colonna, E. Capuzzo, and S. Nicola, “Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women,” Genitourinary Medicine, vol. 70, no. 4, pp. 268–272, 1994. View at Google Scholar · View at Scopus
  19. A. Beltrame, A. Matteelli, A. C. C. Carvalho et al., “Vaginal colonization with Candida spp. in human immunodeficiency virus—infected women: a cohort study,” International Journal of STD and AIDS, vol. 17, no. 4, pp. 260–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. E. Ohmit, J. D. Sobel, P. Schuman et al., “Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women,” Journal of Infectious Diseases, vol. 188, no. 1, pp. 118–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. L. Yang, H. J. Lo, C. C. Hung, and Y. Li, “Effect of prolonged HAART on oral colonization with Candida and candidiasis,” BMC Infectious Diseases, vol. 6, article 8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Cu-Uvin, H. Ko, D. J. Jamieson et al., “Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection,” Clinical Infectious Diseases, vol. 34, no. 10, pp. 1406–1411, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Gatski, D. H. Martin, R. A. Clark, E. Harville, N. Schmidt, and P. Kissinger, “Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among hiv-positive women,” Sexually Transmitted Diseases, vol. 38, no. 3, pp. 163–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Gatski, D. H. Martin, J. Levison et al., “The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women,” Sexually Transmitted Infections, vol. 87, no. 3, pp. 205–208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Bailey, C. Thorne, I. Semenenko et al., “Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine,” PLoS ONE, vol. 7, no. 4, Article ID e34706, 2012. View at Google Scholar
  26. D. H. Watts, M. Fazarri, H. Minkoff et al., “Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women,” Journal of Infectious Diseases, vol. 191, no. 7, pp. 1129–1139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Moodley, D. Wilkinson, C. Connolly, J. Moodley, and A. W. Sturm, “Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus,” Clinical Infectious Diseases, vol. 34, no. 4, pp. 519–522, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. R. L. Sweet and D. V. Landers, “Pelvic inflammatory disease in HIV-positive women,” The Lancet, vol. 349, no. 9061, pp. 1265–1266, 1997. View at Google Scholar · View at Scopus
  29. Ministério da Saúde, Programa Estadual de DST/Aids-SP, Manual para o manejo das doenças sexualmente transmissíveis em pessoas vivendo com HIV, São Paulo, Brazil, 2011.
  30. R. P. Nugent, M. A. Krohn, and S. L. Hillier, “Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation,” Journal of Clinical Microbiology, vol. 29, no. 2, pp. 297–301, 1991. View at Google Scholar · View at Scopus
  31. M. T. C. Duarte, Saúde sexual e reprodutiva de mulheres vivendo com HIV/aids atendidas em hospital dia [Tese de Doutorado], Faculdade de Medicina de Botucatu—Universidade Estadual Paulista “Júlio de Mesquita Filho”, Botucatu, Brazil, 2012.
  32. Secretaria de Estado da Saúde de São Paulo, “Programa Estadual de DST. Divisão de Vigilância Epidemiológica,” Boletim Epidemiológico DST/AID, vol. 27, no. 1, pp. 1–112, 2010. View at Google Scholar
  33. Ministério da Saúde (BR), January 2011, Programa Nacional de DST e Aids [Briefing]. Boletim Epidemiológico, http://www.aids.gov.br/publicacao/2011/boletim_epidemiologico_2011.
  34. R. M. Barbosa and M. A. H. Koyama, “Comportamento e práticas sexuais de homens e mulheres, Brasil 1998 e 2005,” Revista de Saúde Pública, vol. 42, supplement 1, pp. 21–33, 2008. View at Google Scholar
  35. E. Berquó, R. M. Barbosa, and L. P. Lima, “Uso do preservativo: tendências entre 1998 e 2005 na população brasileira,” Revista de Saúde Pública, vol. 42, supplement 1, pp. 34–44, 2008. View at Google Scholar
  36. V. Paiva, M. R. Latorre, N. Gravato, and R. Lacerda, “Enhancing care initiative—Brasil. Sexualidade de mulheres vivendo com HIV/aids em São Paulo,” Cadernos de Saúde Pública, vol. 18, no. 6, pp. 1609–1620, 2002. View at Google Scholar
  37. S. Lambert, A. Keegan, and J. Petrak, “Sex and relationships for HIV positive women since HAART: a quantitative study,” Sexually Transmitted Infections, vol. 81, no. 4, pp. 333–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Mitchell, C. Moreira, D. Fredricks et al., “Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis,” Infectious Diseases in Obstetrics and Gynecology, vol. 2009, Article ID 236919, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. M. Brotman, E. J. Erbelding, R. M. Jamshidi, M. A. Klebanoff, J. M. Zenilman, and K. G. Ghanem, “Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics,” Journal of Pediatric and Adolescent Gynecology, vol. 20, no. 4, pp. 225–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. C. S. Bradshaw, A. N. Morton, J. Hocking et al., “High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence,” Journal of Infectious Diseases, vol. 193, no. 11, pp. 1478–1486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. T. E. Taha, N. I. Kumwenda, G. Kafulafula et al., “Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial,” PLoS Clinical Trials, vol. 2, no. 2, article e10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Srinivasan, C. Liu, C. M. Mitchell et al., “Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis,” PLoS ONE, vol. 5, no. 4, Article ID e10197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. K. A. Fethers, C. K. Fairley, J. S. Hocking, L. C. Gurrin, and C. S. Bradshaw, “Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis,” Clinical Infectious Diseases, vol. 47, no. 11, pp. 1426–1435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. R. S. McClelland, B. A. Richardson, S. M. Graham et al., “A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women,” Sexually Transmitted Diseases, vol. 35, no. 6, pp. 617–623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Myer, L. Kuhn, L. Denny, and T. C. Wright Jr., “Recurrence of symptomatic bacterial vaginosis 12 months after oral metronidazole therapy in HIV-positive and -negative women,” Journal of Infectious Diseases, vol. 194, no. 12, pp. 1797–1799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. R. Schwebke and R. Desmond, “Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases,” Sexually Transmitted Diseases, vol. 32, no. 11, pp. 654–658, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Vutyavanich, P. Pongsuthirak, P. vannareumol, R. A. Ruangsri, and P. Luangsook, “A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis,” Obstetrics and Gynecology, vol. 82, no. 4 I, pp. 550–554, 1993. View at Google Scholar · View at Scopus
  48. E. Colli, M. Landoni, and F. Parazzini, “Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial,” Genitourinary Medicine, vol. 73, no. 4, pp. 267–270, 1997. View at Google Scholar · View at Scopus
  49. S. L. Hillier and R. J. Lau, “Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy,” Clinical Infectious Diseases, vol. 25, supplement 2, pp. S123–S126, 1997. View at Google Scholar · View at Scopus
  50. C. Heinemann and G. Reid, “Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy,” Canadian Journal of Microbiology, vol. 51, no. 9, pp. 777–781, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Cauci, S. Driussi, D. de Santo et al., “Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women,” Journal of Clinical Microbiology, vol. 40, no. 6, pp. 2147–2152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Abbott, “Clinical and microscopic diagnosis of vaginal yeast infection: a prospective analysis,” Annals of Emergency Medicine, vol. 25, no. 5, pp. 587–591, 1995. View at Google Scholar · View at Scopus
  53. M. Cetin, S. Ocak, A. Gungoren, and A. U. Hakverdi, “Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods,” Scandinavian Journal of Infectious Diseases, vol. 39, no. 6-7, pp. 584–588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. L. M. Niccolai, J. J. Kopicko, A. Kassie, H. Petros, R. A. Clark, and P. Kissinger, “Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women,” Sexually Transmitted Diseases, vol. 27, no. 5, pp. 284–288, 2000. View at Google Scholar · View at Scopus
  55. B. van der Pol, J. A. Williams, D. P. Orr, B. E. Batteiger, and J. D. Fortenberry, “Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women,” Journal of Infectious Diseases, vol. 192, no. 12, pp. 2039–2044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Crosby, R. J. DiClemente, G. M. Wingood et al., “Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females,” Sexually Transmitted Infections, vol. 78, no. 5, pp. 360–364, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Gatski and P. Kissinger, “Observation of probable persistent, undetected Trichomonas vaginalis infection among HIV-Positive women,” Clinical Infectious Diseases, vol. 51, no. 1, pp. 114–115, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Kissinger, L. Mena, J. Levison et al., “A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 5, pp. 565–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Goel, P. Bhalla, A. Sharma, and Y. M. Mala, “Lower genital tract infections in HIV-seropositive women in India,” Indian Journal of Sexually Transmitted Diseases, vol. 32, no. 2, pp. 103–107, 2011. View at Google Scholar
  60. K. K. Venkatesh, A. van der Straten, K. H. Mayer et al., “African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring neisseria gonorrhoeae and chlamydia trachomatis in the methods for improving reproductive health in Africa trial,” Sexually Transmitted Diseases, vol. 38, no. 6, pp. 562–570, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. W. L. H. Whittington, C. Kent, P. Kissinger et al., “Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study,” Sexually Transmitted Diseases, vol. 28, no. 2, pp. 117–123, 2001. View at Google Scholar · View at Scopus
  62. C. B. Hosenfeld, K. A. Workowski, S. Berman et al., “Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature,” Sexually Transmitted Diseases, vol. 36, no. 8, pp. 478–489, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. D. S. LaMontagne, K. Baster, L. Emmett et al., “Incidence and reinfection rates of genital chlamydial infection among women aged 16–24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group,” Sexually Transmitted Infections, vol. 83, no. 4, pp. 292–303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. J. A. Schillinger, P. Kissinger, H. Calvet et al., “Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial,” Sexually Transmitted Diseases, vol. 30, no. 1, pp. 49–56, 2003. View at Publisher · View at Google Scholar · View at Scopus